SEERライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary ():

Stats
本日の出来高	0
平均出来高	0
時価総額	0
EPS	$0 ( 2024-02-29 )
次の収益日	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0 (0.00%)

Seer, Inc. 相関

10 最も正の相関
GXGX	0.92
CRON	0.911
NVTSW	0.908
IRBT	0.908
EVLO	0.906
CREG	0.903
SWAV	0.902
EPSN	0.899
HOL	0.898
BCAB	0.897

10 最も負の相関
BRIV	-0.911
PATK	-0.908
ALXN	-0.907
APMI	-0.906
GMFI	-0.905
ENTF	-0.905
CBRG	-0.904
ACAB	-0.903
ENER	-0.903
EMLD	-0.903

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Seer, Inc. 財務諸表

Annual	2023
収益:	$15.18M
総利益:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2023
収益:	$15.18M
総利益:	$1.45M (9.54 %)
EPS:	$-1.350

FY	2022
収益:	$14.69M
総利益:	$6.74M (45.91 %)
EPS:	$-1.420

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-1.164

Financial Reports:

No articles found.

Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.